BRCA-P

Prevention

BRCA-P is a world-first trial that aims to prevent breast cancer in women with a BRCA1 gene mutation.

CAMBRIA-2

Early Breast Cancer

The CAMBRIA-2 clinical trial aims to find out if giving a new treatment called camizestrant is better at stopping cancer from coming back compared with the usual endocrine (hormone) treatments such…

CAPTURE

Metastatic

The CAPTURE clinical trial aims to identify women and men with hormone-receptor positive metastatic breast cancer, who may benefit from a novel combination of drugs that may improve progression free…

EXPERT

Early Breast Cancer

EXPERT aims to improve personalised use of radiation therapy in early breast cancer patients by using a genomic test to identify women who can safely avoid this treatment after surgery and the…

OPTIMA

Early Breast Cancer

The OPTIMA trial aims to find out if using a test called Prosigna can help make safe and accurate decisions about whether or not chemotherapy treatment is needed for participants with ER-positive,…

TUGETHER

Metastatic

TUGETHER aims to treat advanced HER2-positive breast cancer that has come back or spread after anti-HER2 treatment (such as trastuzumab (Herceptin(R)), pertuzumab (Perjeta(R)) or TDM-1 (Kadcycla(R)))…

THE CLINTRIAL REFER APP

The ClinTrial Refer App in an easy way to find a breast cancer clinical trial that may be right for you.

LEARN MORE ABOUT CLINICAL TRIALS

WHY I SUPPORT BREAST CANCER TRIALS